Christopher Taranto - Freshpet Vice President - Procurement and Planning
FRPT Stock | USD 115.86 0.15 0.13% |
President
Mr. Christopher Taranto was promoted as Vice President Procurement and Planning of the Company. Mr. Taranto previously served as the Director of Supply Chain Management at Freshpet where he successfully established functional and sustainable business processes and instituted complex organizational changes. Prior to Freshpet, he served as the Director of Supplier Management, Global Operations, at Pfizer, Inc. Mr. Taranto has over 23 years of experience in procurement, planning, and supply chain management. since 2015.
Tenure | 9 years |
Address | 400 Plaza Drive, Secaucus, NJ, United States, 07094 |
Phone | 201 520 4000 |
Web | https://www.freshpet.com |
Freshpet Management Efficiency
The company has return on total asset (ROA) of (0.0143) % which means that it has lost $0.0143 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.0339) %, meaning that it created substantial loss on money invested by shareholders. Freshpet's management efficiency ratios could be used to measure how well Freshpet manages its routine affairs as well as how well it operates its assets and liabilities. Return On Capital Employed is likely to drop to -0.02 in 2024. Return On Assets is likely to drop to -0.02 in 2024. At this time, Freshpet's Total Current Liabilities is comparatively stable compared to the past year. Liabilities And Stockholders Equity is likely to gain to about 1.5 B in 2024, despite the fact that Change To Liabilities is likely to grow to (2.6 M).Similar Executives
Showing other executives | PRESIDENT Age | ||
Randell Weaver | Nuzee Inc | 66 | |
Kenneth Wolf | Natural Alternatives Internatio | 63 | |
William Lynch | Central Garden Pet | 57 | |
Travis Gorney | Nuzee Inc | 43 | |
Shanoop Kothari | Nuzee Inc | 45 | |
Dan Norman | Natures Sunshine Products | N/A | |
Kay Schwichtenberg | Central Garden Pet | 64 | |
Adriana Mendizabal | Natures Sunshine Products | N/A | |
Mark Cavanaugh | Central Garden Pet | N/A | |
Paul Noack | Natures Sunshine Products | 53 | |
Joseph Baty | Natures Sunshine Products | 59 | |
Rodolfo Spielmann | Central Garden Pet | N/A | |
Bryant Yates | Natures Sunshine Products | 51 | |
Steve Zenker | Central Garden Pet | N/A | |
Eddie Silcock | Natures Sunshine Products | N/A | |
John III | Central Garden Pet | 65 | |
Reza Soltanzadeh | Borealis Foods | N/A |
Management Performance
Return On Equity | -0.0339 | |||
Return On Asset | -0.0143 |
Freshpet Leadership Team
Elected by the shareholders, the Freshpet's board of directors comprises two types of representatives: Freshpet inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Freshpet. The board's role is to monitor Freshpet's management team and ensure that shareholders' interests are well served. Freshpet's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Freshpet's outside directors are responsible for providing unbiased perspectives on the board's policies.
Charles Norris, Chairman of the Board | ||
Richard Kassar, Interim Chairman | ||
Scott Morris, President CoFounder | ||
Leta Priest, Independent Director | ||
Jonathan Marlow, Independent Director | ||
Todd Cunfer, Chief Officer | ||
Cathal Walsh, Co-Founder and Sr. VP of Cooler Operations | ||
Michael Hieger, Senior Vice President - Manufacturing Operations | ||
Christopher Taranto, Vice President - Procurement and Planning | ||
Christopher Harned, Independent Director | ||
Stephen Macchiaverna, Senior Vice President Controller, Secretary | ||
Richard Thompson, CEO and Director | ||
Craig Steeneck, Independent Director | ||
Kathryn Winstanley, Vice President - Marketing | ||
Gerardo PerezCamargo, Vice President - Research & Development | ||
Edward Young, Senior Vice President - Grocery & Mass Sales | ||
William Cyr, CEO, Director | ||
Jacki Kelley, Independent Director | ||
John Speranza, Senior Marketing | ||
Lawrence Coben, Independent Director | ||
Stephen Weise, Executive Vice President - Manufacturing and Supply Chain | ||
Thembeka Machaba, Senior Resources | ||
Christopher Kraus, Chief Officer | ||
Rachel PerkinsUlsh, Vice Relations | ||
Walter George, Independent Director | ||
Robert King, Independent Director | ||
Thomas Farina, Sr. VP of Sales | ||
Daryl Brewster, Independent Director | ||
Katie Turner, IR Contact Officer | ||
David Basto, Independent Director | ||
Lisa Barrette, Vice President - Business Development | ||
Jay Dahlgren, Technology Manufacturing |
Freshpet Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Freshpet a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | -0.0339 | |||
Return On Asset | -0.0143 | |||
Profit Margin | (0.04) % | |||
Operating Margin | 0.07 % | |||
Current Valuation | 5.72 B | |||
Shares Outstanding | 48.29 M | |||
Shares Owned By Insiders | 2.71 % | |||
Shares Owned By Institutions | 97.29 % | |||
Number Of Shares Shorted | 5.28 M | |||
Price To Book | 5.86 X |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Freshpet. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. For more information on how to buy Freshpet Stock please use our How to Invest in Freshpet guide.You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Complementary Tools for Freshpet Stock analysis
When running Freshpet's price analysis, check to measure Freshpet's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Freshpet is operating at the current time. Most of Freshpet's value examination focuses on studying past and present price action to predict the probability of Freshpet's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Freshpet's price. Additionally, you may evaluate how the addition of Freshpet to your portfolios can decrease your overall portfolio volatility.
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
CEOs Directory Screen CEOs from public companies around the world | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data |
Is Freshpet's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Freshpet. If investors know Freshpet will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Freshpet listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.093 | Earnings Share (0.69) | Revenue Per Share 15.923 | Quarterly Revenue Growth 0.299 | Return On Assets (0.01) |
The market value of Freshpet is measured differently than its book value, which is the value of Freshpet that is recorded on the company's balance sheet. Investors also form their own opinion of Freshpet's value that differs from its market value or its book value, called intrinsic value, which is Freshpet's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Freshpet's market value can be influenced by many factors that don't directly affect Freshpet's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Freshpet's value and its price as these two are different measures arrived at by different means. Investors typically determine if Freshpet is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Freshpet's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.